341 related articles for article (PubMed ID: 28833176)
1. Cerebral amyloid angiopathy as a cause of neurodegeneration.
Smith EE
J Neurochem; 2018 Mar; 144(5):651-658. PubMed ID: 28833176
[TBL] [Abstract][Full Text] [Related]
2. Clinical phenotypes of Cerebral Amyloid Angiopathy.
Maia LF; Mackenzie IR; Feldman HH
J Neurol Sci; 2007 Jun; 257(1-2):23-30. PubMed ID: 17341423
[TBL] [Abstract][Full Text] [Related]
3. Cortical atrophy in patients with cerebral amyloid angiopathy: a case-control study.
Fotiadis P; van Rooden S; van der Grond J; Schultz A; Martinez-Ramirez S; Auriel E; Reijmer Y; van Opstal AM; Ayres A; Schwab KM; ; Hedden T; Rosand J; Viswanathan A; Wermer M; Terwindt G; Sperling RA; Polimeni JR; Johnson KA; van Buchem MA; Greenberg SM; Gurol ME
Lancet Neurol; 2016 Jul; 15(8):811-819. PubMed ID: 27180034
[TBL] [Abstract][Full Text] [Related]
4. [Vascular cognitive impairment: the relationship between hypertensive small vessel disease and cerebral amyloid angiopathy].
Tomimoto H
Brain Nerve; 2012 Dec; 64(12):1377-86. PubMed ID: 23209064
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal Cognitive Decline in a Novel Rodent Model of Cerebral Amyloid Angiopathy Type-1.
Popescu DL; Van Nostrand WE; Robinson JK
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32231123
[TBL] [Abstract][Full Text] [Related]
6. Capillary cerebral amyloid angiopathy in Alzheimer's disease: association with allocortical/hippocampal microinfarcts and cognitive decline.
Hecht M; Krämer LM; von Arnim CAF; Otto M; Thal DR
Acta Neuropathol; 2018 May; 135(5):681-694. PubMed ID: 29574591
[TBL] [Abstract][Full Text] [Related]
7. Cerebral Amyloid Angiopathy Is Associated With Executive Dysfunction and Mild Cognitive Impairment.
Case NF; Charlton A; Zwiers A; Batool S; McCreary CR; Hogan DB; Ismail Z; Zerna C; Coutts SB; Frayne R; Goodyear B; Haffenden A; Smith EE
Stroke; 2016 Aug; 47(8):2010-6. PubMed ID: 27338926
[TBL] [Abstract][Full Text] [Related]
8. Cerebral amyloid angiopathy-related cognitive impairment: The search for a specific neuropsychological pattern.
Planton M; Raposo N; Albucher JF; Pariente J
Rev Neurol (Paris); 2017 Nov; 173(9):562-565. PubMed ID: 28993004
[TBL] [Abstract][Full Text] [Related]
9. Vascular cognitive impairment: Modeling a critical neurologic disease in vitro and in vivo.
Helman AM; Murphy MP
Biochim Biophys Acta; 2016 May; 1862(5):975-82. PubMed ID: 26704178
[TBL] [Abstract][Full Text] [Related]
10. The pathophysiology and clinical presentation of cerebral amyloid angiopathy.
Auriel E; Greenberg SM
Curr Atheroscler Rep; 2012 Aug; 14(4):343-50. PubMed ID: 22565298
[TBL] [Abstract][Full Text] [Related]
11. Cerebral Amyloid Angiopathy-Related Microbleeds Correlate with Glucose Metabolism and Brain Volume in Alzheimer's Disease.
Samuraki M; Matsunari I; Yoshita M; Shima K; Noguchi-Shinohara M; Hamaguchi T; Ono K; Yamada M
J Alzheimers Dis; 2015; 48(2):517-28. PubMed ID: 26402015
[TBL] [Abstract][Full Text] [Related]
12. [Sporadic cerebral amyloid angiopathy presenting with dementia and prominent capillary beta-amyloid deposition: a case report].
Yamashita M; Yamamoto T; Yamada M; Okino S; Fujita T
Rinsho Shinkeigaku; 2002 Jun; 42(6):530-5. PubMed ID: 12607981
[TBL] [Abstract][Full Text] [Related]
13. Cerebral amyloid angiopathy: major contributor or decorative response to Alzheimer's disease pathogenesis.
Castellani RJ; Smith MA; Perry G; Friedland RP
Neurobiol Aging; 2004; 25(5):599-602; discussion 603-4. PubMed ID: 15172735
[TBL] [Abstract][Full Text] [Related]
14. Emerging concepts in sporadic cerebral amyloid angiopathy.
Charidimou A; Boulouis G; Gurol ME; Ayata C; Bacskai BJ; Frosch MP; Viswanathan A; Greenberg SM
Brain; 2017 Jul; 140(7):1829-1850. PubMed ID: 28334869
[TBL] [Abstract][Full Text] [Related]
15. Contribution of reactive oxygen species to cerebral amyloid angiopathy, vasomotor dysfunction, and microhemorrhage in aged Tg2576 mice.
Han BH; Zhou ML; Johnson AW; Singh I; Liao F; Vellimana AK; Nelson JW; Milner E; Cirrito JR; Basak J; Yoo M; Dietrich HH; Holtzman DM; Zipfel GJ
Proc Natl Acad Sci U S A; 2015 Feb; 112(8):E881-90. PubMed ID: 25675483
[TBL] [Abstract][Full Text] [Related]
16. The growing clinical spectrum of cerebral amyloid angiopathy.
Wermer MJH; Greenberg SM
Curr Opin Neurol; 2018 Feb; 31(1):28-35. PubMed ID: 29120920
[TBL] [Abstract][Full Text] [Related]
17. Microvasculature changes and cerebral amyloid angiopathy in Alzheimer's disease and their potential impact on therapy.
Weller RO; Boche D; Nicoll JA
Acta Neuropathol; 2009 Jul; 118(1):87-102. PubMed ID: 19234858
[TBL] [Abstract][Full Text] [Related]
18. Cerebral amyloid angiopathy: pathogenesis and effects on the ageing and Alzheimer brain.
Weller RO; Nicoll JA
Neurol Res; 2003 Sep; 25(6):611-6. PubMed ID: 14503015
[TBL] [Abstract][Full Text] [Related]
19. Cortical Thickness and Its Association with Clinical Cognitive and Neuroimaging Markers in Cerebral Amyloid Angiopathy.
Subotic A; McCreary CR; Saad F; Nguyen A; Alvarez-Veronesi A; Zwiers AM; Charlton A; Beaudin AE; Ismail Z; Pike GB; Smith EE
J Alzheimers Dis; 2021; 81(4):1663-1671. PubMed ID: 33998545
[TBL] [Abstract][Full Text] [Related]
20. Neuropsychological Effects of Cerebral Amyloid Angiopathy.
Schrag M; Kirshner H
Curr Neurol Neurosci Rep; 2016 Aug; 16(8):76. PubMed ID: 27357378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
